Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
NCT00802464
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
410
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
BIOLOGICAL:
Herpes zoster vaccine GSK1437173A
BIOLOGICAL:
Placebo
Sponsor
GlaxoSmithKline